Search

Sidebar

Magazine
Events
Videos
Gallery
Blog
Gantry Home

Magazine menu

Home
News
- China News
- Religion
lifestyle
Tech
Financial
Military
Entertainment
Politics
Health
Sport
Environment
Opinion
Weather
Podcasts
Video
Ads

The Power of Truth^®

Sunday, May 11, 2025

Sunday, May 11, 2025

Home
News
- China News
- Religion
lifestyle
Tech
Financial
Military
Entertainment
Politics
Health
Sport
Environment
Opinion
Weather
Podcasts
Video
Ads

You are here:
Financial

Novartis in the lead to acquire cancer drug developer MorphoSys

Details: Staff; 06 February 2024

Financial

Previous Article Anglo American considers deeper cost cuts in face of worst downturn in years
Next Article Chinese brokers restrict cross-border swaps as stocks plunge

Business & Finance

Reuters exclusively reported ^[1] that drug maker Novartis AG (NOVN.S) is in advanced talks to acquire MorphoSys AG (MORG.DE), a developer of cancer treatments that has a market value of 1.6 billion euros ($1.7 billion).

Market Impact

Read more https://www.reutersagency.com/en/reutersbest/article/novartis-in-the-lead-to-acquire-cancer-drug-developer-morphosys/

Previous Article Anglo American considers deeper cost cuts in face of worst downturn in years
Next Article Chinese brokers restrict cross-border swaps as stocks plunge

HUNGRY FOR TRUTH? FEED THE NEED.

The Power of Truth^®

Cookies Policy
Privacy Policy
Terms of Use
Contact

Copyright © 2025 Joomla!. All Rights Reserved. Powered by The Power of Truth® - Designed by JoomlArt.com. Bootstrap is a front-end framework of Twitter, Inc. Code licensed under Apache License v2.0. Font Awesome font licensed under SIL OFL 1.1.